Loading... Please wait... Loading... Please wait...
ESTIMATED
08/10/2023
08/10/2023
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Histogen Inc. last posted its earnings results on Thursday, August 10th, 2023. The company reported $-0.49 earnings per share for the quarter, topping analysts' consensus estimates of $-0.9 by $0.41. The company had revenue of 5,000 for the quarter and had revenue of 3.77 M for the year. Histogen Inc. has generated $-3 earnings per share over the last year ($-3.26 diluted earnings per share) and currently has a price-to-earnings ratio of -0.14. Histogen Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 27th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 11/09/2023 | Q3 2023 | -$0.90 | $5,000 | $5,000 | 08/10/2023 | Q2 2023 | -$0.90 | -$0.49 | 0.41 | $5,000 | 05/11/2023 | Q1 2023 | -$1.47 | -$0.81 | 0.66 | $5,000 | 03/09/2023 | Q4 2022 | -$0.47 | -$0.93 | -0.46 | $4,000 | 11/10/2022 | Q3 2022 | -$1.40 | -$1.01 | 0.39 | $653,053 | $5,000 | 08/11/2022 | Q2 2022 | -$1.40 | -$1.36 | 0.04 | $9.79 M | $5,000 | 05/12/2022 | Q1 2022 | -$1.40 | -$0.27 | 1.13 | $3.76 M | 03/10/2022 | Q4 2021 | -$2.20 | -$1.46 | 0.74 | $5,000 | 11/10/2021 | Q3 2021 | -$2.20 | -$1.84 | 0.36 | $698,454 | $591,000 | 08/11/2021 | Q2 2021 | -$0.17 | -$1.99 | -1.82 | $5,000 | 05/13/2021 | Q1 2021 | -$0.15 | -$2.70 | -2.55 | $318,000 | 03/11/2021 | Q4 2020 | -$0.35 | -$5.10 | -4.75 | $478,000 | 11/10/2020 | Q3 2020 | -$5.34 | $495,000 | 08/13/2020 | Q2 2020 | -$30.30 | $108,000 | 05/01/2020 | Q1 2020 | -$3.12 | $978,000 | 03/11/2020 | Q4 2019 | -$0.70 | $1.56 M | 11/05/2019 | Q3 2019 | -$24.00 | -$2.87 | 21.13 | $19.24 M | $314,000 | 08/07/2019 | Q2 2019 | -$6.60 | $8.90 M | $1.28 M | 05/03/2019 | Q1 2019 | -$1.43 | $7.02 M | 03/08/2019 | Q4 2018 | -$28.80 | -$0.13 | 28.67 | $7.41 M |
|---|
A. Histogen Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 27th, 2024 based off last year's report dates.
A. In the previous quarter, Histogen Inc. (NASDAQ:HSTO) reported $-0.49 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.9 by $0.41.
A. The conference call for Histogen Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Histogen Inc.'s latest earnings report can be read online.
A. Histogen Inc. (NASDAQ:HSTO) has a recorded annual revenue of $3.77 M.
A. Histogen Inc. (NASDAQ:HSTO) has a recorded net income of $3.77 M. Histogen Inc. has generated $-3.26 earnings per share over the last four quarters.
A. Histogen Inc. (NASDAQ:HSTO) has a price-to-earnings ratio of -0.14 and price/earnings-to-growth ratio is -0.
